Macrogenics Inc (MGNX)

Apr 13, 2026

Recap Report: What is the next catalyst for MacroGenics IncQuarterly Profit Report & AI Enhanced Trading Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

MacroGenics (MGNX) price target increased by 11.11% to 4.08 - MSN

Apr 13, 2026

Apr 13, 2026

Sentiment Review: Whats the profit margin of MacroGenics Inc2026 Momentum Check & Real-Time Price Movement Reports - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

B Riley Securities upgrades MacroGenics (MGNX) - MSN

Apr 11, 2026

Apr 11, 2026

MacroGenics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 11, 2026

Apr 10, 2026

Today's Analyst Rating Data for MGNX: Major Upgrade by B. Riley Securities | MGNX Stock News - GuruFocus

Apr 10, 2026

Apr 10, 2026

Today's Analyst Rating Data for MGNX: Major Upgrade by B. Riley - GuruFocus

Apr 10, 2026

Apr 10, 2026

Macrogenics Inc Stock Historical Valuations | HAM:M55 - GuruFocus

Apr 10, 2026

Apr 10, 2026

Macrogenics Inc Stock Intrinsic Values | HAM:M55 - GuruFocus

Apr 10, 2026

Apr 10, 2026

MacroGenics: Oncology Opportunities In Play, But Investing Feels Like A Gamble (MGNX) - Seeking Alpha

Apr 10, 2026

Apr 10, 2026

B.Riley upgrades MacroGenics stock rating on ADAM9 ADC potential By Investing.com - Investing.com South Africa

Apr 10, 2026

Apr 10, 2026

B.Riley upgrades MacroGenics stock rating on ADAM9 ADC potential - Investing.com

Apr 10, 2026

Apr 10, 2026

B. Riley Upgrades MacroGenics to Buy From Neutral, Triples Price Target to $9 From $3 - marketscreener.com

Apr 10, 2026

Apr 09, 2026

MacroGenics gains removal of FDA partial hold on lead program - MSN

Apr 09, 2026

Apr 09, 2026

MacroGenics gains removal of FDA partial hold (MGNX:NASDAQ) - Seeking Alpha

Apr 09, 2026

Apr 08, 2026

MacroGenics says FDA removes partial clinical hold on Phase 2 LINNET study - TipRanks

Apr 08, 2026

Apr 08, 2026

FDA Lifts Partial Clinical Hold on MacroGenics’ LINNET Study for Lorigerlimab in Gynecologic Cancers, Enrollment to Resume - Minichart

Apr 08, 2026

Apr 08, 2026

MacroGenics resumes enrollment in lorigerlimab cancer study By Investing.com - Investing.com Canada

Apr 08, 2026

Apr 08, 2026

FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study - Bitget

Apr 08, 2026

Apr 08, 2026

MacroGenics resumes enrollment in lorigerlimab cancer study - Investing.com

Apr 08, 2026

Apr 08, 2026

FDA Lifts Partial Hold on MacroGenics' (MGNX) LINNET Study - GuruFocus

Apr 08, 2026

Apr 08, 2026

MacroGenics Resumes LINNET Trial After FDA Hold Lifted - TipRanks

Apr 08, 2026

Apr 08, 2026

FDA Lifts Partial Clinical Hold on MacroGenics' LINNET Study; Enrollment to Resume - TradingView — Track All Markets

Apr 08, 2026

Apr 08, 2026

FDA lifts hold on MacroGenics (NASDAQ: MGNX) LINNET gynecologic cancer trial - Stock Titan

Apr 08, 2026

Apr 08, 2026

FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study - The Manila Times

Apr 08, 2026

Apr 08, 2026

MacroGenics can enroll new cancer patients after FDA lifts study hold - Stock Titan

Apr 08, 2026

Apr 08, 2026

[DEF 14A] MACROGENICS INC Definitive Proxy Statement - Stock Titan

Apr 08, 2026

Apr 07, 2026

MacroGenics: Balancing Regulatory Setbacks with Pipeline Promise () - aktiencheck.de

Apr 07, 2026

Apr 07, 2026

Dip Buying: Can MacroGenics Inc be the next market leader2026 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Volatility Watch: What is the next catalyst for MacroGenics IncWeekly Stock Recap & High Return Trade Opportunity Guides - baoquankhu1.vn

Apr 07, 2026

Apr 04, 2026

Medtronic Outperforms MacroGenics in Financial Comparison - National Today

Apr 04, 2026

Apr 02, 2026

MGNX Earnings History & Surprises | EPS & Revenue Results | MACROGENICS INC (NASDAQ:MGNX) - ChartMill

Apr 02, 2026

Mar 31, 2026

MacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Mar 31, 2026

Mar 31, 2026

MacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of “Hold” by Brokerages - Defense World

Mar 31, 2026

Mar 31, 2026

Retail Trends: Can MacroGenics Inc disrupt its industryPortfolio Value Report & Smart Money Movement Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 29, 2026

Investment Report: Can MacroGenics Inc expand its profit margins2026 Selloffs & Weekly Chart Analysis and Guides - baoquankhu1.vn

Mar 29, 2026

Mar 27, 2026

Vanguard reports 0 shares in MacroGenics (NASDAQ: MGNX) - Stock Titan

Mar 27, 2026

Mar 26, 2026

Aug Drivers: How does MacroGenics Inc compare to its peersMarket Activity Recap & Short-Term Swing Trade Alerts - baoquankhu1.vn

Mar 26, 2026

Mar 26, 2026

MacroGenics Secures Financial Runway Ahead of Pivotal Clinical Milestones () - aktiencheck.de

Mar 26, 2026

Mar 26, 2026

Treasury Yields: Can MacroGenics Inc disrupt its industry2026 AllTime Highs & Verified High Yield Trade Plans - baoquankhu1.vn

Mar 26, 2026

Mar 25, 2026

Patterns Watch: What is the next catalyst for MacroGenics IncCEO Change & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

VIX Spike: Can MacroGenics Inc be the next market leaderTrade Entry Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026

MacroGenics (NASDAQ:MGNX) Share Price Crosses Above Fifty Day Moving AverageTime to Sell? - MarketBeat

Mar 24, 2026

Mar 21, 2026

Why is MacroGenics stock sinking Tuesday? - MSN

Mar 21, 2026

Mar 20, 2026

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus

Mar 20, 2026

Mar 18, 2026

Sentiment Review: Will MacroGenics Inc outperform the market in YEAR2026 Big Picture & Fast Gain Stock Tips - baoquankhu1.vn

Mar 18, 2026

Mar 17, 2026

Bull Run: Is MacroGenics Inc attractive for institutional investorsWeekly Stock Analysis & Verified Momentum Watchlists - baoquankhu1.vn

Mar 17, 2026

Mar 14, 2026

MacroGenics Inc earnings missed by $0.03, revenue topped estimates - Investing.com Nigeria

Mar 14, 2026